The rising prevalence in GLP-1 agonists for metabolic health has generated a discussion about delivery routes : skin-applied devices versus tablets . Usually , GLP-1 treatments were only available in https://philipudmg375855.diowebhost.com/96154302/glp-1-transdermal-delivery-systems-vs-tablets-which-suitable-for-the-patient